Samuel Agresta
CIK 1748961 · View on SEC EDGAR ↗
First SEC filing: Oct. 22, 2020 · Latest: Oct. 22, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | OKUR | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 7, 2026 | OKUR | D | 18,588 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Aug. 7, 2026 | OKUR | A | 18,588 | — | — | 18,588 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 7, 2026 | OKUR | D | 131,396 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Aug. 7, 2026 | OKUR | A | 131,396 | — | — | 131,396 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 28, 2021 | FHTX | A | 100,000 | — | — | 100,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 7, 2026 | OKUR | Employee Stock Option (right to buy) | Class A Common Stock (50,000) | $4.14 | Aug. 6, 2036 | 50,000 | Acquired |
| Aug. 7, 2026 | OKUR | Employee Stock Option (right to buy) | Class A Common Stock (18,588) | $13.99 | Feb. 5, 2034 | 18,588 | Disposed |
| Aug. 7, 2026 | OKUR | Employee Stock Option (right to buy) | Class A Common Stock (18,588) | $4.14 | Feb. 5, 2034 | 18,588 | Acquired |
| Aug. 7, 2026 | OKUR | Employee Stock Option (right to buy) | Class A Common Stock (131,396) | $18.20 | Oct. 3, 2034 | 131,396 | Disposed |
| Aug. 7, 2026 | OKUR | Employee Stock Option (right to buy) | Class A Common Stock (131,396) | $4.14 | Oct. 3, 2034 | 131,396 | Acquired |
| Jan. 28, 2021 | FHTX | Stock Option (Right to Buy) | Common Stock (100,000) | $16.63 | Jan. 27, 2031 | 100,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
OKUR
M.D.(5)Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $482,000 | — | — | $211,131 | $144,600 | — | $14,000 | $851,731 |
| 2024 | $416,727 | $183,360 | — | $2,228,619 | — | — | $12,362 | $2,841,068 |
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $412,000 | — | — | — | $99,573 | — | — | $1,053,797 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.